Howard Margolese, MD, M.Sc., FRCPC
psychopharmacology
first episode psychosis
schizophrenia
clinical trials
About Us
|
|
---|
Research
|
|
---|
Services
|
|
---|
Displaying 20 result(s).
Howard Margolese, MD, M.Sc., FRCPCpsychopharmacology first episode psychosis schizophrenia clinical trials |
Errol Marliss, MD, FRCPCNutrition metabolism diabetes obesity insulin resistance CTB |
Marc Martel, PhDchronic pain mental health opioids cannabinoids |
James Martin, MDasthma immunology cysteinyl leukotrienes airway remodeling epidermal growth factor receptor CTB |
Paul Martineau, HBSc, MDCM, FRCSC, ABOS, SCOSMsport medicine trauma osteoimmunology biomechanics implant design CTB |
Thomas Mavrakanas, MD, M.Sc.chronic kidney disease kidney failure cardiovascular disease anticoagulation cardiorenal syndromes CORE |
Nancy Mayo, PhDchronic disease health outcomes rehabilitation health services disability CORE |
Bruce Mazer, MDAsthma food allergy immune therapies intravenous immunoglobulin B-lymphocytes and mucosal responses CTB |
Christine McCusker, MD, M.Sc.allergy developmental immunology asthma immunomodulation CTB |
Hugh McMillan, MD, M.Sc., FRCPC, FAANneuromuscular pediatric clinical translational research spinal muscular atrophy muscular dystrophy |
Peter McPherson, PhDendocytosis neurons membrane trafficking neurogenerative disease Parkinson's disease |
Ari-Nareg Meguerditchian, MD, MSc, FRCS(C), FACSHealth outcomes cancer quality of care treatment guidelines health informatics tools CORE |
Arielle Mendel, MD, M.Sc.Systemic autoimmune rheumatic diseases systemic vasculitis systemic lupus erythematosus patient safety and quality improvement medication safety CORE |
Janine Mendola, PhDVision perception visual cortex neuroimaging physiology CTB |